Patents by Inventor Laura Catherine Funk Hrycyniak

Laura Catherine Funk Hrycyniak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EX VIVO SYSTEMS AND METHODS FOR DETERMINING THE EFFECT OF A DRUG OR OTHER AGENT ON A TISSUE
    Publication number: 20220326220
    Abstract: Provided are ex vivo systems and methods of predicting the response of a drug or other agent on a tissue. In some embodiments, the systems and methods comprise cutting a tissue into tissue fragments, adding a drug or other agent to the tissue fragments based on an estimated tumor content, and performing an ex vivo measurement on the tissue fragments.
    Type: Application
    Filed: June 7, 2022
    Publication date: October 13, 2022
    Inventors: Jonathan Daniel Oliner, Neil Anthony, Sean Caenepeel, Laura Catherine Funk Hrycyniak, John Rafter, Tomasz Zal
  • EX VIVO SYSTEMS AND METHODS FOR DETERMINING THE EFFECT OF A DRUG OR OTHER AGENT ON A TISSUE
    Publication number: 20220205976
    Abstract: Provided are ex vivo systems and methods of predicting the response of a drug or other agent on a tissue. In some embodiments, the systems and methods comprise cutting a tissue into tissue fragments, adding a drug or other agent to the tissue fragments based on an estimated tumor content, and performing an ex vivo measurement on the tissue fragments.
    Type: Application
    Filed: December 30, 2021
    Publication date: June 30, 2022
    Inventors: Jonathan Daniel Oliner, Neil Anthony, Sean Caenepeel, Laura Catherine Funk Hrycyniak, John Rafter, Tomasz Zal
  • Ex vivo systems and methods for determining the effect of a drug or other agent on a tissue
    Patent number: 11366101
    Abstract: Provided are ex vivo systems and methods of predicting the response of a drug or other agent on a tissue. In some embodiments, the systems and methods comprise cutting a tissue into tissue fragments, adding a drug or other agent to the tissue fragments based on an estimated tumor content, and performing an ex vivo measurement on the tissue fragments.
    Type: Grant
    Filed: December 30, 2021
    Date of Patent: June 21, 2022
    Assignee: Elephas Biosciences Corporation
    Inventors: Jonathan Daniel Oliner, Neil Anthony, Sean Caenepeel, Laura Catherine Funk Hrycyniak, John Rafter, Tomasz Zal